Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Canakinumab in Type 1 Diabetes”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Study completedNCT00947427
What this trial is testing

Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes

Who this might be right for
Type 1 DiabetesPreservation of Insulin SecretionNewly Diagnosed Type 1 Diabetes+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 71
Testing effectiveness (Phase 2)WithdrawnNCT01322321
What this trial is testing

ACZ885 in Type 1 Diabetes Mellitus

Who this might be right for
Diabetes MellitusDiabetes Type 1
Novartis Pharmaceuticals

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation